Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. High Paying Jobs, Compensation Information and Expert Network Connections

lightbulbWhat are the highest paying jobs at Neurocrine Biosciences, Inc.?

Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia. The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.


Market Cap$9.1 billion
Revenue$1 billion
5 Year Trend+0.7%
Net Income$93.4 million
Annual Report
stats icon
Total value of jobs:
stats icon
Total Jobs:
stats icon
Average Pay:
stats icon
Total Experts:
stats icon
% Masters:

Top Experts at Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. Compensation

Medical Director



Average Compensation:$150,000

View All Compensation view all icon